haylaavo

OMKARCHEM

OMKARCHEM · NSE · inactive
3.41
-0.17 (-4.75%)
as of 28 Apr 2026 close
Open
3.41
High
3.41
Low
3.41
Prev close
3.58
52w high
7.91
05 Jun 2025
52w low
3.35
30 Mar 2026
VWAP
3.41
Delivery %
—
n/a
Volume 23,987 · turnover ₹82,000 · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 10 Feb 2011
Market cap
₹7 cr
Series
BZ
F&O
No
Status
Inactive since 29 Apr 2026

Source: NSE equity master · as of 28 Apr 2026 · market cap = shares (30 Sept 2026 filing) × close

Market cap
₹7 cr
P/B
0.37
BV ₹9
ROE (TTM)
-8.2%
ROCE -7.0%
Debt / equity
0.17
P/E (TTM)
—
loss-making
P/S (TTM)
855.74
Revenue TTM
₹0 cr
Net profit TTM
₹-2 cr
Net margin TTM
-18775.6%
OPM -9790.2%
EV / EBITDA
—
Interest cover
—
Revenue growth
—
latest quarter YoY
Profit growth
—
latest quarter YoY
Dividend yield
—
last 12 months

Standalone · last four quarters to 2026-06-30 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 07:46 IST
  • 21 Oct 2022 19:31
    Exchange query

    OMKARCHEM : Significant increase in volume has been observed in Omkar Speciality Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

  • 18 Aug 2022 10:56
    Exchange query

    The Exchange has sought clarification from Omkar Speciality Chemicals Limited with respect to announcement dated 13-Aug-2022 informing about Outcome of Board Meeting.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Confirmation from Director that there are no material reasons for resignation other than that disclosed 2. Detailed Reasons for Resignation 3. Resignation letter 4. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees The response of

  • 12 Oct 2021 18:50
    Exchange query

    Significant movement in price has been observed in Omkar Speciality Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

  • 28 Jul 2021 12:54
    Exchange query

    Significant movement in price has been observed in Omkar Speciality Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Omkar Speciality Chemicals Limited has submitted their response.

    PDF · -
  • 27 Jul 2021 17:27
    Exchange query

    Significant movement in price has been observed in Omkar Speciality Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

  • 15 Nov 2019 19:55
    Exchange query

    OMKARCHEM:The Exchange has sought clarification from Omkar Speciality Chemicals Limited with respect to announcement dated 13-Nov-2019, regarding Board meeting held on November 13, 2019. On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment. The response of the Company is awaited.

  • 17 Jun 2019 15:02
    Exchange query

    :The Exchange had sought clarification from Omkar Speciality Chemicals Limited with respect to announcement dated 30-May-2019, regarding Outcome of the Board meeting held on May 30, 2019. On basis of above the Company was required to clarify following: 1. Brief profile (in case of appointment) The response of the Company is attached.

  • 06 Jun 2019 13:54
    Exchange query

    OMKARCHEM:The Exchange has sought clarification from Omkar Speciality Chemicals Limited with respect to announcement dated 30-May-2019, regarding Outcome of the Board meeting held on May 30, 2019. On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)The response of the Company is awaited.

  • 06 Dec 2018 10:58
    Exchange query

    Significant movement in price has been observed in Omkar Speciality Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Omkar Speciality Chemicals Limited has submitted their response.

    PDF · -
  • 05 Dec 2018 17:29
    Exchange query

    Significant movement in price has been observed in Omkar Speciality Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

  • 29 Aug 2016 12:41
    Exchange query

    OMKARCHEM:The Exchange had sought clarification from Omkar Speciality Chemicals Limited with respect to announcement dated August 22, 2016, regarding a press release dated August 22, 2016 titled "Successful Commissioning of Expanded Capacity at Unit 1 in Badlapur Total capacity at Unit 1 stands at 900 MTPA Will manufacture Advanced Intermediates used in Pharmaceutical Sector ".On the basis of above the reply of the company is attached

    PDF · -
  • 24 Aug 2016 18:42
    Exchange query

    OMKARCHEM:The Exchange has sought clarification from Omkar Speciality Chemicals Limited with respect to announcement dated August 22, 2016, regarding a press release dated August 22, 2016 titled "Successful Commissioning of Expanded Capacity at Unit 1 in Badlapur Total capacity at Unit 1 stands at 900 MTPA Will manufacture Advanced Intermediates used in Pharmaceutical Sector ".On basis of above the Company is required to clarify following:1. Existing capacity;2. Investment required;3. Mode of financing;4. Rationale.The response of the Company is awaited.

  • 21 Dec 2015 16:33
    Exchange query

    The Exchange had sought clarification from Omkar Speciality Chemicals Limited with respect to annonucement dated December 15, 2015 regarding revision in rating on the bank facilities of the Company.The reply from the Company is attached.

    PDF · -
  • 17 Dec 2015 20:26
    Exchange query

    The Exchange has sought clarification from Omkar Speciality Chemicals Limited with respect to annonucement dated December 15, 2015 regarding revision in rating on the bank facilities of the Company.On basis of above, Company is required to clarify :1. Reason for such downward revision in rating. The reply from the Company is awaited.

  • 16 Apr 2012 11:09
    Exchange query

    Omkar Speciality Chemicals Limited has informed the Exchange vide its letter dated April 16, 2012 with reference to the news article dated April 10, 2012, bearing headline: "Omkar Chemicals to invest Rs. 100 Crore in new Chiplun facility". Omkar Speciality Chemicals Limited has clarified to the Exchange that there is misconstruction of facts in the aforesaid article. The said proposed expansion of the Company is a part of the Company's strategic growth policy driven by the market demands and the Company proposes to fund these expansions out of internal accruals and suitable bank borrowings. Th

  • 30 Mar 2011 16:23
    Exchange query

    Price movement : Significant price movement has been observed in Omkar Speciality Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Omkar Speciality Chemicals Limited has vide its letter inter-alia stated," We would like to inform that there are no events, information or price sensitive information that the Company is withholding which may have a bearing on the operations or performance of the Company."

Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries